Integrated global profiling of cancer

Nature Reviews Cancer

Volumn 4, Issue 8, 2004, Pages 638-644

  Hanash, Samir ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; ENVIRONMENTAL FACTOR; GENOMICS; HUMAN; MUTATION; PRIORITY JOURNAL; PROTEOMICS; REVIEW; TUMOR GROWTH;

EID: 3543061612     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1414     Document Type: Review

References (37)

1. Tapon, N. Modeling transformation and metastasis in Drosophila. Cancer Cell 4, 333-335 (2003).
2. Rangarajan, A. & Weinberg, R. A. Comparative biology of mouse versus human cells: modelling human cancer in mice. Nature Rev. Cancer 3, 952-359 (2003).
3. Lamb, J. et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114, 323-334 (2003).
4. Creighton, C. et al. Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice. Genome Biol. 4, R46 (2003).
5. Albertson, D. G., Collins, C., McCormick, F. & Gray, J. W. Chromosome aberrations in solid tumors. Nature Genet. 34, 369-376 (2003).
6. Albertson, D. G. & Pinkel, D. Genomic microarrays in human genetic disease and cancer. Hum. Mol. Genet. 2, R145-R152 (2003).
7. Shi, H. et al. Triple analysis of the cancer epigenome: an integrated microarray system for assessing gene expression, DNA methylation, and histone acetylation. Cancer Res. 63, 2164-2171 (2003).
8. Feltus, F. A., Lee, E. K., Costello, J. F., Plass, C. & Vertino, P. M. Predicting aberrant CpG island methylation. Proc. Natl Acad. Sci. USA 100, 12253-12258 (2003).
9. Ntzani, E. E. & Ioannidis, J. P. Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet 362, 1439-1444 (2003).
10. Simon, R. Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data. Br. J. Cancer 89, 1599-1604 (2003).
11. Rhodes, D. R. et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl Acad. Sci. USA 101, 9309-9314 (2004).
12. Lieberfarb, M. E. & Lin, M. Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP. Cancer Res. 63, 4781-4785 (2003).
13. Pollack, J. R. et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl Acad. Sci. USA 99, 12963-12968 (2002).
14. Wu, R. et al. Amplification and overexpression of the L-MYC proto-oncogene in ovarian carcinomas. Am. J. Pathol. 162, 1603-1610 (2003).
15. Hanash, S. Disease proteomics. Nature 422, 226-232 (2003).
16. Ruggero, D. & Pandolfi, P. P. Does the ribosome translate cancer? Nature Rev. Cancer 3, 179-192 (2003).
17. Inoki, K., Zhu, T. & Guan, K. L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590 (2003).
18. Nishizuka, S. & Charboneau, L. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl Acad. Sci. USA 100, 14229-14234 (2003).
19. Beer, D. G. et al. Gene-expression profiles predict survival of patients with lung adenocarcinomas. Nature Med. 8, 816-824 (2002).
20. Chen, G. et al. Protein profiles associated with survival in lung adenocarcinoma. Proc. Natl Acad. Sci. USA 100, 13537-13542 (2003).
21. Brichory, F. M. et al. An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc. Natl Acad. Sci. USA 98, 9824-9829 (2001).
22. Albert, P. S. & Shih, J. H. Modeling tumor growth with random onset. Biometrics 59, 897-906 (2003).
23. Telford, J. J., Saltzman, J. R., Kuntz, K. M. & Syngal, S. Impact of preoperative staging and chemoradiation versus postoperative chemoradiation on outcome in patients with rectal cancer: a decision analysis. J. Natl Cancer Inst. 96, 191-201 (2004).
24. Merlino, G. & Noonan, F. P. Modeling gene-environment interactions in malignant melanoma. Trends Mol. Med. 9, 102-108 (2003).
25. Semenza, G. L. Targeting HIF-1 for cancer therapy. Nature Rev. Cancer 3, 721-732 (2003).
26. Kanehisa, M., Goto, S., Kawashima, S. & Nakaya, A. The KEGG databases at GenomeNet. Nucleic Acids Res. 30, 42-46 (2002).
27. Doniger, S. W. et al. MAPPFinder; using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol. 4, R7 (2003).
28. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature Genet. 25, 25-29 (2000).
29. Schacherer, F. et al. The TRANSPATH signal transduction database: a knowledge base on signal transduction networks. Bioinformatics, 17, 1053-1057 (2001).
30. Koike, A., Kobayashi, Y. & Takagi, T. Kinase pathway database: An integrated protein-kinase and NLP-Based protein-interaction resources. Genome Res. 13, 1231-1243 (2003).
31. Bader, G. D., Betel, D. & Hogue, C. W. BIND: The biomolecular interation network database. Nucleic Acids Res. 31, 248-250 (2003).
32. Xenarios, I. et al. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions. Nucleic Acids Res. 30, 303-305 (2002).
33. Gelovani-Tjuvajev, J. & Blasberg, R. In vivo imaging of molecular-genetic targets for cancer therapy. Cancer Cell 4, 327-333 (2003).
34. Zerhouni, E. The NIH Roadmap. Science 302, 63-72 (2003).
35. Wheeler, D. L. et al. Database resources of the National Center for Biotechnology Information: update. Nucleic Acids Res. 32 (Database issue), D35-D40 (2004).
36. Covitz, P. A. et al. caCORE: A common infrastructure for cancer informatics. Bioinformatics 19, 2404-2412 (2003).
37. Zeeberg, B. R. et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol. 4, R28 (2003).